Samsung biologics makes US entry with $280 million GSK site deal
Samsung Biologics has acquired its first US manufacturing facility, purchasing a former GlaxoSmithKline site in Maryland...
Read more
Samsung
Why Samsung, Amgen, and Biocon are investing in US pharma facilities
As global trade tensions mount and tariff policy becomes less predictable, international pharmaceutical giants are turning...
Read more
How green electronics are reshaping global manufacturing
Sustainability is now a core principle in electronics manufacturing. With the market for green electronics projected...
Read more